Evidence map›Paper›PMID 35957046›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Advanced Respiratory Models for Hazard Assessment of Nanomaterials-Performance of Mono-, Co- and Tricultures.

Laura Maria Azzurra Camassa, Elisabeth Elje, Espen Mariussen, Eleonora Marta Longhin, Maria Dusinska, Shan Zienolddiny-Narui, Elise Rundén-Pran

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Alkaline Comet Assay for Assessment of DNA Damage.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Application of the Comet Assay in Advanced In Vitro Models.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura Maria Azzurra CamassaNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.ORCID 0000-0002-5041-942X
Elisabeth EljeNILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.
Espen MariussenNILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.ORCID 0000-0001-5150-942X
Eleonora Marta LonghinNILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.
Maria DusinskaNILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.ORCID 0000-0003-1358-1652
Shan Zienolddiny-NaruiNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.ORCID 0000-0001-9747-9625
Elise Rundén-PranNILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.ORCID 0000-0002-5541-4513

Funding

EEA and Norway Grants, TEPCAN project NOR/POLNOR/TEPCAN/0057/2019-00H2020 project RiskGone 8144259H2020 project TWINALT 952404 - H2020-WIDESPREAD-2020-5Norwegian Research Council, NanoBioReal project 288768Norwegian Research Council, PhD project (E.E.) 272412/F40
6 · The paper itself

Abstract

Advanced in vitro models are needed to support next-generation risk assessment (NGRA), moving from hazard assessment based mainly on animal studies to the application of new alternative methods (NAMs). Advanced models must be tested for hazard assessment of nanomaterials (NMs). The aim of this study was to perform an interlaboratory trial across two laboratories to test the robustness of and optimize a 3D lung model of human epithelial A549 cells cultivated at the air-liquid interface (ALI). Potential change in sensitivity in hazard identification when adding complexity, going from monocultures to co- and tricultures, was tested by including human endothelial cells EA.hy926 and differentiated monocytes dTHP-1. All models were exposed to NM-300K in an aerosol exposure system (VITROCELL

Indexed as

3D lung modelair–liquid interfacenanotoxicologyNM-300Ktricultures

Identifiers

PMID35957046
PMCPMC9370172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.